Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Unknown 3Terminated 2Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 2Thymoma 1Testicular Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1

Interventions

Cisplatin 508Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 328Paclitaxel 324Oxaliplatin 323Gemcitabine 320Docetaxel 310Fluorouracil 282Drug Therapy 243apatinib 242Bevacizumab 228camrelizumab 214Etoposide 200Irinotecan 175Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138Pemetrexed 136Cytarabine 136anlotinib 135toripalimab 130Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 116Radiosurgery 116

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × isophosphamide mustard × Clear all
NCT01340547 2013-07-18

Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors

Alaunos Therapeutics

Phase 1 Unknown
24 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01555710 2013-05-21

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)

Alaunos Therapeutics

Phase 3 Unknown
548 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01242072 2012-07-18

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Alaunos Therapeutics

Phase 1 Unknown
12 enrolled
GenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Osteosarcoma, Testicular Neoplasms, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡